D.E. Shaw & Co’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.05M | Buy |
560,827
+3,674
| +0.7% | +$58K | ﹤0.01% | 2166 |
|
|
2025
Q4 | $10.2M | Buy |
557,153
+224,452
| +67% | +$3.78M | 0.01% | 1738 |
|
|
2025
Q3 | $4.88M | Sell |
332,701
-499,862
| -60% | -$8.57M | ﹤0.01% | 2226 |
|
|
2025
Q2 | $15.2M | Sell |
832,563
-692,964
| -45% | -$14.1M | 0.02% | 1212 |
|
|
2025
Q1 | $30.3M | Sell |
1,525,527
-1,541,048
| -50% | -$26.7M | 0.04% | 718 |
|
|
2024
Q4 | $52.6M | Sell |
3,066,575
-2,197,520
| -42% | -$41.3M | 0.06% | 555 |
|
|
2024
Q3 | $105M | Sell |
5,264,095
-1,560,422
| -23% | -$24.3M | 0.14% | 260 |
|
|
2024
Q2 | $76.3M | Buy |
6,824,517
+1,442,799
| +27% | +$12.1M | 0.11% | 331 |
|
|
2024
Q1 | $35.5M | Sell |
5,381,718
-1,131,835
| -17% | -$6.19M | 0.05% | 617 |
|
|
2023
Q4 | $29.4M | Sell |
6,513,553
-1,058,140
| -14% | -$3.91M | 0.04% | 707 |
|
|
2023
Q3 | $27.1M | Sell |
7,571,693
-602,124
| -7% | -$2.32M | 0.04% | 691 |
|
|
2023
Q2 | $30.2M | Sell |
8,173,817
-37,756
| -0.5% | -$140K | 0.05% | 644 |
|
|
2023
Q1 | $27.2M | Sell |
8,211,573
-296,836
| -3% | -$1.03M | 0.04% | 714 |
|
|
2022
Q4 | $33M | Buy |
8,508,409
+2,664,613
| +46% | +$8.22M | 0.06% | 622 |
|
|
2022
Q3 | $14.2M | Buy |
5,843,796
+1,011,404
| +21% | +$2.43M | 0.02% | 1083 |
|
|
2022
Q2 | $9.57M | Buy |
4,832,392
+2,930,104
| +154% | +$5.76M | 0.02% | 1421 |
|
|
2022
Q1 | $3.48M | Buy |
1,902,288
+1,812,981
| +2,030% | +$2.83M | ﹤0.01% | 2732 |
|
|
2021
Q4 | $126K | Buy |
+89,307
| New | +$117K | ﹤0.01% | 5012 |
|
|
2021
Q3 | – | Sell |
-211,692
| Closed | -$339K | – | 4927 |
|
|
2021
Q2 | $339K | Buy |
+211,692
| New | +$372K | ﹤0.01% | 4214 |
|
|
2020
Q4 | – | Sell |
-10,030
| Closed | -$24K | – | 3874 |
|
|
2020
Q3 | $24K | Buy |
+10,030
| New | +$27.5K | ﹤0.01% | 3768 |
|
Other funds holding ADMA
VCM
VPM
N
